Industri

Storage Operations: MVS Pharma Controlled Storage Condi...

MVS Pharma controlled storage conditions overview: Proper storage is a continuou...

MHRA launches call for evidence on AI regulation in UK ...

The initiative aims to shape future standards and safeguards for the way AI is u...

J&J receives FDA approval for lung cancer therapy

The approval covers all existing indications for Rybrevant. The SC formulation r...

Pfizer India partners with Cipla for marketing and dist...

Cipla to market and distribute five Pfizer medicines in India under new agreeme...

EU GDP Quarantine and Inspection: Controlled Release of...

EU GDP quarantine and inspection: Quarantine and inspection are essential contro...

EC approves Incyte’s Minjuvi combo for follicular lymphoma

FL is the most common slow-growing B-cell non-Hodgkin lymphoma form. Minjuvi is ...

Alnylam plans $250m investment in Norton manufacturing ...

This is claimed to become the first fully dedicated small-interfering RNA (siRNA...

Alembic Pharmaceuticals gets USFDA final approval for T...

Alembic Pharmaceuticals Limited (Alembic) announced that it has received final ...

Harbour BioMed and BMS sign multi-specific antibody collab

Harbour BioMed will work alongside BMS to progress and expedite the programmes a...

Senores Pharmaceuticals to acquire Apnar Pharma and fiv...

Senores Pharmaceuticals announced that it has entered into a definitive agreeme...

Lupin receives positive CHMP opinion for biosimilar Ran...

Lupin has announced that the Committee for Medicinal Products for Human Use (CH...

INCOG reveals $200m injectable drug expansion in Indiana

The company’s plans are expected to increase the capacity for injectable drug pr...

RPG Life Sciences appoints Amol Lone as Chief Financial...

RPG Life Sciences, the leading pharmaceutical company of RPG Group, today annou...

Agilent Technologies inaugurates India Refurbishment Ce...

Agilent Technologies, a global leader in life sciences, diagnostics, and applie...

AstraZeneca announces new phase III clinical data for b...

AstraZeneca announced new Phase III clinical data for baxdrostat, an investigat...

IDMA PAC 2025: Industry leaders call for AI and sustain...

The 24th IDMA Pharmaceutical Analysts’ Conference (PAC) commenced on December 1...